TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability

19Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Target of Egr1 (TOE1) is a nuclear protein localized primarily in nucleoli and Cajal bodies that was identified as a downstream target of the immediate early gene Egr1. TOE1 displays a functional deadenylation domain and has been shown to participate in spliceosome assembly. We report here that TOE1 can function as an inhibitor of HIV-1 replication and show evidence that supports a direct interaction of TOE1 with the viral specific transactivator response element as part of the inhibitory mechanism. In addition, we show that TOE1 can be secreted by activated CD8+ T lymphocytes and can be cleaved by the serine protease granzyme B, one of the main components of cytotoxic granules. Both full-length and cleaved TOE1 can spontaneously cross the plasma membrane and penetrate cells in culture, retaining HIV-1 inhibitory activity. Antiviral potency of TOE1 and its cell-penetrating capability have been identified to lie within a 35-amino-acid region containing the nuclear localization sequence.

Cite

CITATION STYLE

APA

Sperandio, S., Barat, C., Cabrita, M. A., Gargaun, A., Berezovski, M. V., Tremblay, M. J., & De Belle, I. (2015). TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability. Proceedings of the National Academy of Sciences of the United States of America, 112(26), E3392–E3401. https://doi.org/10.1073/pnas.1500857112

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free